Your Current Location : Fund Card : Fund Summary |
|
|
|
Nippon India Pharma Fund IDCW Direct |
|
[Equity: Sectoral] |
|
|
|
Fund Details |
Fund Type |
Dividend |
Launch Date |
14 Jan 2013 |
Corpus(Cr.) |
8689.0 |
Scheme NAV |
179.728 |
Equity(%) |
95.6 |
52 Week High |
187.892 |
Debt(%) |
4.4 |
52 Week Low |
139.357 |
Others(%) |
0.0 |
Exit Load |
1% for redemption within 30 days |
Minimum Investment |
- |
Availability |
Open |
Entry Load |
- |
Expense Ratio(%) |
0.91 |
Scheme Benchmark |
BSE Healthcare TRI |
Broader Benchmark |
NSE - Nifty 50 TRI |
|
|
Scheme Objective |
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies. |
|
Last 10 Dividends |
Date of Dividend Declaration |
Dividend (Individual) Per Unit(Rs.) |
Dividend (Corporate) Per Unit(Rs.) |
23-02-2024 |
10.00 |
10.00 |
25-02-2022 |
3.50 |
3.50 |
26-02-2021 |
6.00 |
6.00 |
28-02-2020 |
3.98 |
3.98 |
01-03-2019 |
4.43 |
4.43 |
01-03-2018 |
6.00 |
6.00 |
|
|
|
|
|
|
|
|
|
|
|